Related Experiment Video
Updated: May 29, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Lysine392, a K63-linked ubiquitination site in NEMO, mediates inflammatory osteoclastogenesis and osteolysis
Muhammad Alhawagri1, Yasuhiro Yamanaka, Dean Ballard
1Department of Orthopaedics, Washington University School of Medicine, St. Louis, MO, USA.
Abstract:
PMMA particles released from bone implants are considered major contributor to osteolysis and subsequent implant failure. Although the ensuing inflammatory response has been described, the mechanisms underlying PMMA particulate-induced osteolysis remain enigmatic. In previous studies, we have established that activation of Nuclear factor kappa-B (NF-κB) and MAP kinase pathways plays a central role in the pathogenesis of inflammatory osteolysis. Specifically, we have shown that impeding IKK complex assembly, and thus subsequent NF-κB activation, dampens particle-induced osteolysis. The IKK complex consists of IKKα, IKKβ, and IKKγ, also known as NEMO. NEMO has no catalytic activity and serves as a scaffold protein facilitating assembly and distal activation of NF-κB signaling. In fact, blocking binding of NEMO with IKKα/β abolishes NF-κB activity. In the current study, we identify Lysine 392 residue in NEMO as crucial mediator of PMMA particle-induced inflammatory osteoclastogenesis and osteolysis. Using mice in which NEMO-K392R mutation has been introduced, we provide evidence that PMMA-induced osteoclasts and osteolytic responses are impaired. Furthermore, we show that this impairment is likely due to poor activation of NF-κB and Erk, but not other MAP kinases. Our findings suggest that NEMO Lysine392, a well-established K63-linked polyubiquitination site, is an important mediator of PMMA-induced osteolysis. Therefore, this NEMO motif should be considered as a target to combat PMMA particle-induced osteolysis.
Insights
Polymethyl methacrylate (PMMA) particles from bone implants cause osteolysis. Targeting the NEMO Lysine 392 residue in the IKK complex can impair this process by affecting NF-κB and Erk activation.
Area of Science:
- Biomedical Engineering
- Immunology
- Orthopedics
Background:
- Polymethyl methacrylate (PMMA) particles from bone implants are a major cause of osteolysis and implant failure.
- The precise mechanisms of PMMA-induced osteolysis, particularly the inflammatory pathways, remain unclear.
- Nuclear factor kappa-B (NF-κB) and MAP kinase pathways are known to be central to inflammatory osteolysis.
Purpose of the Study:
- To identify key molecular mediators in PMMA particle-induced osteolysis.
- To investigate the role of the NEMO protein, specifically Lysine 392, in osteoclastogenesis and osteolysis.
- To explore potential therapeutic targets for combating PMMA-induced osteolysis.
Main Methods:
- Utilized genetically modified mice with a NEMO-K392R mutation.
- Assessed the impact of this mutation on PMMA particle-induced osteoclast formation and osteolytic responses.
- Analyzed the activation of NF-κB and various MAP kinases (including Erk) in response to PMMA particles.
Main Results:
- Mice with the NEMO-K392R mutation exhibited impaired PMMA-induced osteoclastogenesis and osteolysis.
- This impairment was associated with reduced activation of NF-κB and Erk signaling pathways.
- Other MAP kinase pathways did not appear to be significantly affected.
Conclusions:
- Lysine 392 of NEMO is a critical mediator in PMMA particle-induced inflammatory osteoclastogenesis and osteolysis.
- The NEMO Lysine 392 residue plays a significant role in activating NF-κB and Erk signaling, crucial for osteolysis.
- Targeting the NEMO Lysine 392 motif presents a promising strategy for preventing or treating PMMA-induced osteolysis.
Related Concept Videos
Osteoclasts in Bone Remodeling
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Nuclear Protein Sorting
The Nucleolus
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...